MedTrace Logo

Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer

NCT01254591 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2013-08-26

No results posted yet for this study

Summary

RATIONALE: Diagnostic procedures, such as positron emission tomography/computed tomography (PET/CT) scanning before surgery, may help measure the extent of disease.

PURPOSE: This clinical trial is studying PET/CT scanning before surgery in patients with non-small cell lung cancer, colorectal cancer, breast cancer, esophageal cancer, or head and neck cancer.

Conditions

Interventions

OTHER

18F-fluoromisonidazole

OTHER

fluorescence angiography

OTHER

laboratory biomarker analysis

PROCEDURE

infrared thermography

PROCEDURE

magnetic resonance imaging

PROCEDURE

therapeutic conventional surgery

RADIATION

[18F]-ML-10

RADIATION

fludeoxyglucose F 18

RADIATION

rubidium Rb-82

Sponsors & Collaborators

  • University College London (UCL) Cancer Institute

    lead OTHER

Principal Investigators

  • Peter Ell, MD · University College London Hospitals

Study Design

Purpose
DIAGNOSTIC

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2013-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01254591 on ClinicalTrials.gov